Watch for Tirzepatide for Sleep Apnea
September 2026
Tirzepatide (Zepbound) will be the first med approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity.
It should be used alongside lifestyle changes, including a reduced-calorie diet and increased physical activity.
Using tirzepatide 10 or 15 mg SC weekly reduces breathing interruptions by about 20 episodes/hour more than placebo at 1 year...in patients with or without continuous positive airway pressure (CPAP).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive